Latest Articles

Publication Date
Endometrial regeneration and the role of the extracellular matrix: mechanisms, challenges, and future perspectives.

Endometrial regeneration is a cornerstone of reproductive health, with the extracellular matrix (ECM) playing a pivotal role in tissue repair, regeneration, and fertility restoration. Dysregulated ECM remodeling is at the …

Published: Aug. 5, 2025, midnight
Lenvatinib Plus Pembrolizumab Versus Chemotherapy in Advanced Endometrial Cancer: Efficacy and Safety Insights - Cureus

Lenvatinib Plus Pembrolizumab Versus Chemotherapy in Advanced Endometrial Cancer: Efficacy and Safety Insights Cureus

Published: July 30, 2025, 7:21 a.m.
Image-guided cryoablation for uterine diseases: a systematic review.

Cryoablation is a minimally invasive treatment, with limited research on uterine diseases. This paper provides a review of image-guided cryoablation for the treatment of gynecologic diseases, such as uterine myoma, …

Published: July 29, 2025, midnight
Dienogest use and the risk of breast and gynecologic cancers: A nationwide population-based study.

To evaluate whether dienogest exposure is associated with the risk of breast, endometrial, or tubo-ovarian cancer in women with endometriosis.

Published: July 29, 2025, midnight
RUBY Trial: Real-World Safety, Efficacy Analysis, and Quality of Life Considerations in Endometrial Cancer - OncLive

RUBY Trial: Real-World Safety, Efficacy Analysis, and Quality of Life Considerations in Endometrial Cancer OncLive

Published: July 24, 2025, 2:03 p.m.
SIENDO Study: Long-Term Safety and Efficacy of Selinexor Maintenance in Endometrial Cancer - OncLive

SIENDO Study: Long-Term Safety and Efficacy of Selinexor Maintenance in Endometrial Cancer OncLive

Published: July 24, 2025, 1:49 p.m.
The Role of Plant-Based Diets and Personalized Nutrition in Endometriosis Management: A Review.

Endometriosis is a chronic, estrogen-dependent inflammatory condition that affects multiple organ systems and significantly impairs the quality of life in women of reproductive age. While conventional hormonal therapies may alleviate …

Published: July 13, 2025, midnight
Patient Safety Network Papers Restored Amid Lawsuit From Doctors - MSN

Patient Safety Network Papers Restored Amid Lawsuit From Doctors MSN

Published: June 18, 2025, 6:06 p.m.
Patient Safety Network Papers Restored Amid Lawsuit From Doctors - MedPage Today

Patient Safety Network Papers Restored Amid Lawsuit From Doctors MedPage Today

Published: June 17, 2025, 8:38 p.m.
Safety and pharmacology of AMY109, a long-acting anti-interleukin-8 antibody, for endometriosis: a double-blind, randomized phase 1 trial.

To evaluate the safety and pharmacokinetics/pharmacodynamics of AMY109, an anti-interleukin-8 recycling antibody in a first-in-human phase 1 trial in healthy volunteers (HVs) and patients with endometriosis.

Published: May 2, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!